|
Volumn 33, Issue 2, 2001, Pages 171-177
|
Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model
|
Author keywords
Bifidobacterium lactis; Diarrhea; Escherichia coli; Immune function; Probiotic; Rotavirus
|
Indexed keywords
PROBIOTIC AGENT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BIFIDOBACTERIUM;
BIFIDOBACTERIUM ANIMALIS;
BODY WEIGHT;
CONTROLLED STUDY;
DIARRHEA;
DISEASE SEVERITY;
DRUG EFFICACY;
ESCHERICHIA COLI;
FECES MICROFLORA;
FOOD INTAKE;
IMMUNE RESPONSE;
LEUKOCYTE;
LYMPHOCYTE PROLIFERATION;
MALE;
NONHUMAN;
PHAGOCYTOSIS;
PRIORITY JOURNAL;
ROTAVIRUS;
SWINE;
T LYMPHOCYTE;
TREATMENT OUTCOME;
WEIGHT GAIN;
ANIMALS;
BIFIDOBACTERIUM;
CASE-CONTROL STUDIES;
COLONY COUNT, MICROBIAL;
DIARRHEA;
DISEASE MODELS, ANIMAL;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
ESCHERICHIA COLI INFECTIONS;
FECES;
IMMUNITY, CELLULAR;
MALE;
PROBIOTICS;
ROTAVIRUS INFECTIONS;
SWINE;
TIME FACTORS;
ANIMALIA;
BIFIDOBACTERIUM ANIMALIS;
ESCHERICHIA COLI;
ROTAVIRUS;
|
EID: 0034868931
PISSN: 02772116
EISSN: None
Source Type: Journal
DOI: 10.1097/00005176-200108000-00014 Document Type: Article |
Times cited : (172)
|
References (51)
|